also engage pattern recognition receptors such as TLR2, TLR4, and NOD2 in a controlled manner, resulting in low-level immune priming that can improve responsiveness to immunization [99], as demonstrated in He et al. [100] for COVID-19 vaccination. The gene discussed is TLR4; the disease is COVID-19.